Non-invasive prenatal testing: ethical issues explored [PDF]
This paper explores the ethical implications of introducing non-invasive prenatal diagnostic tests (NIPD tests) in prenatal screening for foetal abnormalities. NIPD tests are easy and safe and can be performed early in pregnancy. Precisely because of these features, it is feared that informed consent may become more difficult, that both testing and ...
de Jong, Antina +4 more
openaire +2 more sources
Non invasive prenatal testing for single gene disorders:Exploring the ethics [PDF]
Non-invasive prenatal testing for single gene disorders is now clearly on the horizon. This new technology offers obvious clinical benefits such as safe testing early in pregnancy.
A de Jong +65 more
core +2 more sources
Non-Invasive Prenatal Testing (NIPT): Reliability, Challenges, and Future Directions
Non-invasive prenatal testing was first discovered in 1988; it was primarily thought to be able to detect common aneuploidies, such as Patau syndrome (T13), Edward Syndrome (T18), and Down syndrome (T21).
Siva Shantini Jayashankar +6 more
doaj +1 more source
Routinization of prenatal screening with the non-invasive prenatal test: pregnant women’s perspectives [PDF]
AbstractDue to the favorable test characteristics of the non-invasive prenatal test (NIPT) in the screening of fetal aneuploidy, there has been a strong and growing demand for implementation. In the Netherlands, NIPT is offered within a governmentally supported screening program as a first-tier screening test for all pregnant women (TRIDENT-2 study ...
Karuna R. M. van der Meij +11 more
openaire +4 more sources
Non-invasive prenatal diagnosis (NIPD) for single gene disorders: cost analysis of NIPD and invasive testing pathways [PDF]
OBJECTIVE: Evaluate the costs of offering non-invasive prenatal diagnosis (NIPD) for single gene disorders compared to traditional invasive testing to inform NIPD implementation into clinical practice.
Chitty, LS +6 more
core +1 more source
Controversies in implementing non‐invasive prenatal testing in a public antenatal care program
Women's autonomy and an inclusive society for all individuals are highly valued in Norway. The Norwegian Biotechnology Act changed in 2020 allowing first‐trimester screening and cell‐free DNA for common trisomies to all pregnant women.
Kjell Åsmund Blix Salvesen +2 more
doaj +1 more source
Preferences for Prenatal Tests for Cystic Fibrosis: A Discrete Choice Experiment to Compare the Views of Adult Patients, Carriers of Cystic Fibrosis and Health Professionals [PDF]
As new technologies enable the development of non-invasive prenatal diagnosis (NIPD) for cystic fibrosis (CF), research examining stakeholder views is essential for the preparation of implementation strategies.
Chitty, L +4 more
core +1 more source
Innovative method for reducing uninformative calls in non-invasive prenatal testing [PDF]
Non-invasive prenatal testing or NIPT is currently among the top researched topic in obstetric care. While the performance of the current state-of-the-art NIPT solutions achieve high sensitivity and specificity, they still struggle with a considerable ...
Budis, Jaroslav +13 more
core +2 more sources
Challenges and clinical implications of discordant non-invasive prenatal testing results: insights from two case studies [PDF]
Non-invasive prenatal testing (NIPT) has transformed prenatal screening, offering high sensitivity and specificity in the detection of common fetal aneuploidies.
Slavyana Galeva +2 more
doaj +3 more sources
Genetic Counseling and Management: The First Study to Report NIPT Findings in a Romanian Population
Background and Objectives: Non-invasive prenatal testing (NIPT) has been confirmed as the most accurate screening test for trisomies 21, 18, 13, sex chromosomes aneuploidies and several microdeletions. This study aimed to assess the accuracy of cell free
Cristina Gug +11 more
doaj +1 more source

